insights_auto
Why is ROIV down 2.40%?
Dive Deeperchevron_right
ROIV:NASDAQ
Roivant Sciences Ltd
$34.59
arrow_downward
-2.40%(-0.85) 1D
$34.59
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 12, 3:57:15 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$34.92
High
$35.41
Low
$34.55
Mkt. cap
24.99B
Avg. vol.
9.12M
Volume
3.54M
52-wk high
$42.50
52-wk low
$15.99
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
Open
$34.92
High
$35.41
Low
$34.55
Mkt. cap
24.99B
Avg. vol.
9.12M
Volume
3.54M
52-wk high
$42.50
52-wk low
$15.99
EPS
-$0.39
Beta
1.10
Shares outstanding
722.32M
No. of employees
721
News stories
From web sources and news partners
Benzinga
·
7 hours ago
This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
https://www.dars.gov.et/
·
1 month ago
Roivant Sciences (ROIV) Holds at $34.58 After Modest 0.49% Gain - Moving Average Ribbon
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd